Fluid Management and Edema Control Flashcards

In advanced heart failure complicating CKD (cardiorenal syndrome), which fluid management approach requires careful balance between treating heart failure volume overload and avoiding worsening kidney function?

Answer: Moderate sodium restriction (2–3 g/day) and individualized fluid restriction (1.5–2 L/day), guided by daily weight monitoring, urine output tracking, and biomarkers (BNP, creatinine trends) — avoiding both hypervolemia and hypovolemia

Cardiorenal syndrome requires careful titration: hypervolemia worsens cardiac function and renal venous congestion; hypovolemia (from over-diuresis) reduces renal perfusion and worsens CKD. Moderate, individualized sodium and fluid restriction guided by daily weight, urine output, and biomarkers is the evidence-based approach.

A dialysis patient develops severe intradialytic hypotension (IDH) repeatedly. After optimizing UFR and assessing dry weight, the dietitian reviews nutritional factors. Which dietary change could CONTRIBUTE to IDH?

Answer: Excessive carbohydrate intake causing post-meal vasodilation (splanchnic blood pooling) if the patient eats a large high-carbohydrate meal immediately before or during dialysis

Post-meal splanchnic hyperemia (blood flow to the GI tract after carbohydrate-rich meals) reduces effective intravascular volume and can precipitate IDH, particularly if the patient eats a large meal immediately before or during dialysis when volume removal is occurring.

The RAAS (renin-angiotensin-aldosterone system) plays a central role in edema formation in CKD. Which dietary intervention has the MOST direct effect on suppressing RAAS activation in CKD patients?

Answer: Sodium restriction, which reduces volume stimulus for RAAS activation and enhances the antiproteinuric and antihypertensive effects of ACE inhibitors/ARBs

Volume depletion of any cause activates RAAS. Sodium restriction reduces extracellular volume and blunts the volume-dependent RAAS stimulus. It also dramatically enhances the efficacy of ACE inhibitors/ARBs by reducing sodium-angiotensin interaction, lowering both blood pressure and proteinuria.

Which hormone, newly targeted by pharmaceutical agents, plays a role in sodium and fluid retention in CKD and is ALSO regulated by dietary potassium intake?

Answer: Aldosterone, which promotes renal sodium retention and potassium excretion — and is suppressed by higher dietary potassium intake (which reduces aldosterone need)

Aldosterone is the primary mineralocorticoid regulating sodium retention and potassium excretion in the distal nephron. Dietary potassium intake influences aldosterone levels: higher potassium intake suppresses aldosterone (less need for K+ excretion), potentially reducing sodium retention. Aldosterone antagonists (finerenone) are now used in CKD.

A CKD patient on a 2 g/day sodium diet reports following the restriction carefully but continues to have significant fluid retention. The dietitian should investigate which commonly overlooked source of sodium?

Answer: Medications: sodium-containing medications including sodium bicarbonate tablets, effervescent vitamin C, some antacids, IV normal saline infusions, and oral rehydration salts — can provide 1–3+ g/day of 'hidden' sodium not accounted for in dietary recall

Many medications contain significant sodium: sodium bicarbonate supplements (each 650 mg tablet = ~175 mg sodium), effervescent tablets (vitamin C, antacids), some PPIs formulated as sodium salts. These medication-derived sodium sources are not captured in dietary food recall but contribute meaningfully to total daily sodium intake.

Which complication of severe, prolonged edema in CKD patients can impair nutritional intake and should be specifically assessed by the renal dietitian?

Answer: Gastroparesis and reduced gastric motility from ascites or severe visceral edema impairing gastric emptying and causing early satiety, nausea, and anorexia

Ascites and severe visceral/gut edema increase intra-abdominal pressure, impairing gastric emptying and causing gastroparesis-like symptoms (early satiety, nausea, vomiting). This directly reduces oral food intake and contributes to malnutrition in CKD patients with significant fluid overload.